Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
NRC
BUYNRC Health · Healthcare · United States · $474M · Avg Vol: $2M/d
COMPANY DESCRIPTION
National Research Corporation provides healthcare experience and engagement software and services, collecting and analyzing patient, employee, and physician feedback. It is a market leader in patient experience measurement and improvement solutions for healthcare organizations, offering proprietary methodologies and benchmarks. The company helps healthcare providers enhance quality of care, improve patient satisfaction, and meet regulatory requirements through actionable insights.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 151.6M | 148.6M | 143.1M | 137.4M | -3.2% | 140.0M | 142.6M | 154.5M | 6.0% |
| EPS | 1.28 | 1.26 | 1.05 | 0.50 | -26.9% | 0.24 | 0.33 | 0.35 | -15.9% |
| Shares | 24.6M | 24.2M | 23.1M | 22.6M | -8.1% | 22.1M | — | — | — |
| Debt | 22.2M | 36.7M | 62.7M | 79.0M | 52.7% | 90.4M | — | — | — |
| Equity | 72.0M | 49.0M | 31.3M | 14.0M | -42.1% | — | — | — | — |
| Op CF | 36.3M | 38.1M | 34.6M | 26.4M | -10.0% | 29.5M | — | — | — |
| Inv CF | -9.8M | -15.8M | -20.3M | -10.7M | — | — | — | — | — |
| Fin CF | -55.6M | -40.7M | -16.8M | -15.8M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of NRC are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| NRC | NRC Health(you) | $474M | 72 | BUY |
| SLP | Simulations Plus, Inc. | $371M | 80 | STRONG BUY |
| MDRX | Veradigm Inc. | $517M | 59 | HOLD |
| CTEV | Claritev Corporation | $368M | 60 | HOLD |
| TALK | Talkspace, Inc. | $873M | 63 | HOLD |
| GDRX | GoodRx Holdings, Inc. | $1.0B | 79 | BUY |
| HSTM | HealthStream, Inc. | $793M | 85 | STRONG BUY |
| OMDA | Omada Health, Inc. | $1.2B | 67 | BUY |
| WEAV | Weave Communications, Inc. | $491M | 47 | HOLD |
| AMWL | American Well Corporation | $181M | 79 | BUY |
Peer medians: ROE -25.8% · P/E 30.1x · Gross margin 55.7%